A Nondepleting Anti-CD19 Antibody Impairs B Cell Function and Inhibits Autoimmune Diseases

Scientists described a nondepleting, high-affinity anti–human CD19 antibody LY3541860 that exhibited potent B cell inhibitory activities. LY3541860 inhibited B cell activation, proliferation, and differentiation of primary human B cells with high potency.